A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
for Chronic Myeloid Leukemia, Chronic Phase
18 locations incl. Birmingham
Sponsor: Terns, Inc.
Sex: All·Age: 18+
Code: NCT06163430·Phase 1, Phase 2·Recruiting